• Maternal RSV nanoparticle vaccine transfers antibodies through placenta

    7 days ago - By Healio

    SAN FRANCISCO - A respiratory syncytial virus F nanoparticle vaccine was immunogenic in pregnant women and elicited antibodies that were transferred efficiently through the placenta to infants, according to research presented at IDWeek. The results have led to a landmark, ongoing phase 3 study, according to researchers.
    Pedro A. Piedra, MD, a professor of virology, microbiology and pediatrics at Baylor College of Medicine, and colleagues reported that RSV is the leading cause of infant lower respiratory tract infection and hospitalization throughout the world, with the greatest
    Read more ...

     

  • Vaccination reduces flu-related hospitalization risk in pregnant women by 40%

    7 days ago - By Healio

    Vaccination reduced the risk that pregnant women would experience influenza-related hospitalization by 40% during six recent influenza seasons, according to results from a multinational study published in Clinical Infectious Diseases.
    “Expecting mothers face a number of threats to their health and the health of their baby during pregnancy, and getting the flu is one of them,” Allison L. Naleway, PhD, senior investigator and associate director of science programs in the Kaiser Permanente Center for Health Research, said in a news release. “This study's findings
    Read more ...